Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01866904
Other study ID # NIS-CMC-DUM-2013/1
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date June 19, 2013
Est. completion date March 31, 2017

Study information

Verified date August 2018
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high atherothrombotic risk.


Description:

TIGRIS is a multinational, multi-centre, observational, prospective, longitudinal cohort study which will include stable CAD patients with history of MI 1-3 years ago and high risk of developing atherothrombotic events in a real world setting. The follow-up period is 3 years.

Patients will undergo clinical assessments and receive standard medical care as determined by the treating physician. Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the study.


Recruitment information / eligibility

Status Terminated
Enrollment 9284
Est. completion date March 31, 2017
Est. primary completion date March 31, 2017
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Stable CAD patients aged 50 years or older with documented history of presumed spontaneous MI with their most recent MI occurring 1 to 3 years prior to enrollment and have at least 1 of the following risk factors: age = 65 years; diabetes mellitus requiring medication; documented history of a second prior presumed spontaneous MI (>1 year ago); documented history of angiographic evidence of multivessel coronary artery disease; chronic renal dysfunction.

Exclusion Criteria:

- Presence of serious co-morbidities in the opinion of the investigator which may limit life expectancy (<1 year)

- Current participation in a blinded randomized clinical trial.

- Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient

- Patients receiving treatment of ticagrelor beyond 12 months, or off label use of ticagrelor.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Argentina Research Site Buenos Aires
Argentina Research Site Cordoba
Argentina Research Site Corrientes
Argentina Research Site Mendoza
Argentina Research Site Salta
Argentina Research Site Santa Fe de la Vera Cruz
Australia Research Site Brisbane Queensland
Australia Research Site Coffs Harbour New South Wales
Australia Research Site Concord New South Wales
Australia Research Site Epping Victoria
Australia Research Site Fremantle Western Australia
Australia Research Site Kogarh New South Wales
Australia Research Site Liverpool New South Wales
Australia Research Site Nambour Queensland
Australia Research Site Nedlands Western Australia
Australia Research Site Newcastele New South Wales
Australia Research Site Parkville Victoria
Australia Research Site Richmond Victoria
Australia Research Site Southport Queensland
Australia Research Site St Leonards New South Wales
Australia Research Site Wollongong New South Wales
Australia Research Site Woolloongabba Queensland
Belgium Research Site Aalst
Belgium Research Site Bonheiden
Belgium Research Site Brasschaat
Belgium Research Site Bruxelles
Belgium Research Site Genk
Belgium Research Site Gent
Belgium Research Site Kortrijk
Belgium Research Site Oostende
Belgium Research Site Overpelt
Belgium Research Site Veurne
Brazil Research Site Blumenal Santa Cantarina
Brazil Research Site Campo Grande Mato Grosso Do Sul
Brazil Research Site Marilia Sao Paulo
Brazil Research Site Sao Jose do Rio Preto Sao Paulo
Canada Research Site Brampton Ontario
Canada Research Site Cambridge Ontario
Canada Research Site Greenfield Park Quebec
Canada Research Site Hamilton Ontario
Canada Research Site London Ontario
Canada Research Site Montreal Quebec
Canada Research Site Newmarket Ontario
Canada Research Site North York Ontario
Canada Research Site Quebec
Canada Research Site Saint John New Brunswick
Canada Research Site Saint-Jerome Quebec
Canada Research Site Thetford Mines Quebec
Canada Research Site Toronto Ontario
Canada Research Site Windsor Ontario
China Research Site Beijing Beijing
China Research Site Changchun Jilin
China Research Site Chongqing Chongqing
China Research Site Guangzhou Guangdong
China Research Site Jinan Shandong
China Research Site Jinzhou Liaoning
China Research Site Kunming Yunnan
China Research Site Lanzhou Gansu
China Research Site Nanjing Jiangsu
China Research Site Shanghai Shanghai
China Research Site Taiyuan Shanyuan
China Research Site Tianjin Tianjin
China Research Site Wuxi Jiangsu
China Research Site Xian Shanxi
China Research Site Zhenjiang Jiangsu
Colombia Research Site Barranquilla Atlantico
Colombia Research Site Bucaramanga Santander Dept
Colombia Research Site Cali Valle Del Cauca
Colombia Research Site Cartagena Caldas
Colombia Research Site Manizales Caldas
Colombia Research Site Medellin Antioquia
Denmark Research Site Alborg
Denmark Research Site arhus N
Denmark Research Site Haderslev
Denmark Research Site Hellerup
Denmark Research Site Kobenhavn
Denmark Research Site Kobenhavn NV
Denmark Research Site Kobenhavn S
Denmark Research Site Randers
Finland Research Site Jyvaskyla
Finland Research Site Rovaniemi
Finland Research Site Tampere
Finland Research Site Turku
France Research Site Abbeville
France Research Site Arras
France Research Site Boulogne-Billancourt
France Research Site Briis Sous Forge
France Research Site Corbeille Essone
France Research Site Dijon Cedex
France Research Site La Rochelle
France Research Site Langres
France Research Site Le Chesnay
France Research Site Le Coudray
France Research Site Lyon
France Research Site Marseille
France Research Site Nice Cedex 1
France Research Site Roubaix
France Research Site Salouel
France Research Site Toulouse
Germany Research Site Berlin
Germany Research Site Bochum
Germany Research Site Chemnitz
Germany Research Site Cloppenburg
Germany Research Site Coburg
Germany Research Site Dresden
Germany Research Site Erfurt
Germany Research Site Erlangen
Germany Research Site Essen
Germany Research Site Frankfurt
Germany Research Site Frankfurt M
Germany Research Site Hamburg
Germany Research Site Heidelberg
Germany Research Site Kiel
Germany Research Site Koblenz
Germany Research Site Koln
Germany Research Site Leipzig
Germany Research Site Leverkusen
Germany Research Site Lubeck
Germany Research Site Ludwigshafen
Germany Research Site Mainz
Germany Research Site Merseburg
Germany Research Site Monchengladbach
Germany Research Site Munchen
Germany Research Site Potsdam
Germany Research Site Soltau
Germany Research Site Stuttgart
Germany Research Site Ulm
India Research Site Bangalore Karnataka
India Research Site Chennai Tamil Nadu
India Research Site Hyderabad Andhra Pradesh
India Research Site Indore Madhya Pradesh
India Research Site Jaipur Rajasthan
India Research Site Kolkata West Bengal
India Research Site Madurai Tamil Nadu
India Research Site Mohali Punjab
India Research Site Mumbai Maharashtra
India Research Site New Delhi Delhi
India Research Site Noida Uttar Pradesh
India Research Site Pune Maharashtra
India Research Site Surat Gujarat
India Research Site Thrisur Kerala
India Research Site Trivandrum Kerala
Italy Research Site Ancona
Italy Research Site Bologna
Italy Research Site Catania
Italy Research Site Lagosanto FE
Italy Research Site Lido di Camaiore
Italy Research Site Massa Carrara
Italy Research Site Milano
Italy Research Site Napoli
Italy Research Site Nuoro
Italy Research Site Palermo
Italy Research Site Perugia
Italy Research Site Prato
Italy Research Site Sassari
Italy Research Site Treviso
Japan Research Site Amagasaki-shi Hyogo
Japan Research Site Bunkyo-ku Tokyo
Japan Research Site Chiba-shi Chiba
Japan Research Site Chuo-Ku Tokyo
Japan Research Site Fukui-shi Fukui
Japan Research Site Fukuoka-shi Fukuoka
Japan Research Site Hirakata-shi Osaka
Japan Research Site Hiroshima-shi Hiroshima
Japan Research Site Isehara-shi Kanagawa
Japan Research Site Izunokuni-shi Shizuoka
Japan Research Site Kanazawa-shi Ishikawa
Japan Research Site Kisarazu-shi Chiba
Japan Research Site Komatsujima-shi Tokushima
Japan Research Site Kouchi-shi Kouchi
Japan Research Site Kumamoto-shi Kumamoto
Japan Research Site Kurume-shi Fukuoka
Japan Research Site Kusatsu-shi Shiga
Japan Research Site Maebashi-shi Gunma
Japan Research Site Matsuyama-shi Ehime
Japan Research Site Morioka-shi Iwate
Japan Research Site Osaka-shi Osaka
Japan Research Site Sagamihara-shi Kanagawa
Japan Research Site Sapporo-shi Hokkaido
Japan Research Site Sendai-shi Miyagi
Japan Research Site Shizuoka-shi Shizuoka
Japan Research Site Suita-shi Osaka
Japan Research Site Tenri-shi Nara
Japan Research Site Tomakomai-shi Hokkaido
Japan Research Site Toyoake-shi Aichi
Japan Research Site Wakayama-shi Wakayama
Japan Research Site Yokohama-shi Kanagawa
Korea, Republic of Research Site Busan Seo-gu
Korea, Republic of Research Site Chungcheongbuk-do Cheongju-si
Korea, Republic of Research Site Daegu Nam-gu
Korea, Republic of Research Site Daejeon Jung-gu
Korea, Republic of Research Site Gwangju South Jeolla
Korea, Republic of Research Site Jeonju-si Jeollabuk-do
Korea, Republic of Research Site Jinju Gyeongsangnam-do
Korea, Republic of Research Site Seoul Sudogwon
Korea, Republic of Research Site Wonju-si Gangwon-do
Mexico Research Site Chihuahua
Mexico Research Site Ciudad de Mexico Distrito Federal
Mexico Research Site Guadalajara Jalisco
Mexico Research Site Oaxaca
Mexico Research Site Puebla
Mexico Research Site Queretaro Queretaro De Arteaga
Mexico Research Site San Luis Potosi
Mexico Research Site Tijuana Baja California
Mexico Research Site Toluca Estado De Mexico
Mexico Research Site Torreon Coahuila
Netherlands Research Site Amsterdam
Netherlands Research Site Arnhem
Netherlands Research Site Blaricum
Netherlands Research Site Delft
Netherlands Research Site Den Haag
Netherlands Research Site Doetinchem
Netherlands Research Site Ede
Netherlands Research Site Groningen
Netherlands Research Site Haarlem
Netherlands Research Site Hardenberg
Netherlands Research Site Heerlen
Netherlands Research Site Hoofddorp
Netherlands Research Site Hoogeveen
Netherlands Research Site IJssel
Netherlands Research Site Meppel
Netherlands Research Site Sittard-Geleen
Netherlands Research Site Zutphen
Norway Research Site Fredrikstad
Norway Research Site Oslo
Norway Research Site Stavanger
Portugal Research Site Braga
Portugal Research Site Canelas
Portugal Research Site Faro
Portugal Research Site Lisboa
Portugal Research Site Porto
Portugal Research Site Senhora da Hora
Portugal Research Site Setubal
Portugal Research Site Viana do Castelo
Romania Research Site Arad
Romania Research Site Braila
Romania Research Site Bucuresti
Romania Research Site Cluj Napoca
Romania Research Site Craiova
Romania Research Site Drobeta - Turnu Severin
Romania Research Site Focsani
Romania Research Site Pitesti
Romania Research Site Sibiu
Romania Research Site Slatina
Romania Research Site Timisoara
Spain Research Site Alicante
Spain Research Site Almeria
Spain Research Site Barcelona Catalonia
Spain Research Site Baza Granada
Spain Research Site Caceres Extremadura
Spain Research Site Granada
Spain Research Site Lleida
Spain Research Site Madrid
Spain Research Site Murcia
Spain Research Site Palma de Mallorca Balearic Islands
Spain Research Site Santiago de Compostela Galicia
Spain Research Site Sevilla Andalusia
Spain Research Site Toledo Castile-La Mancha
Spain Research Site Vic Catalonia
Turkey Research Site Ankara
Turkey Research Site Aydin
Turkey Research Site Diyarbak?r
Turkey Research Site Istanbul
Turkey Research Site Merkez
Turkey Research Site Mersin
United Kingdom Research Site Airdrie
United Kingdom Research Site Cambridge
United Kingdom Research Site East Kilbride
United Kingdom Research Site London
United Kingdom Research Site Portadown
United Kingdom Research Site Sheffield
United Kingdom Research Site Taunton
United Kingdom Research Site Wolverhampton
United States Research Site Abington Pennsylvania
United States Research Site Arlington Heights Illinois
United States Research Site Auburn Maine
United States Research Site Bangor Maine
United States Research Site Burlington Vermont
United States Research Site Chapel Hill North Carolina
United States Research Site Clearwater Florida
United States Research Site Columbia Maryland
United States Research Site Doylestown Pennsylvania
United States Research Site Durham North Carolina
United States Research Site Englewood Illinois
United States Research Site Falls Church Virginia
United States Research Site Houston Texas
United States Research Site Huntsville Alabama
United States Research Site Jackson Michigan
United States Research Site Jackson Tennessee
United States Research Site Lebanon Indiana
United States Research Site Los Angeles California
United States Research Site Manassas Virginia
United States Research Site Manhasset New York
United States Research Site Miami Florida
United States Research Site Minneapolis Minnesota
United States Research Site Pittsburgh Pennsylvania
United States Research Site Plano Texas
United States Research Site Providence Rhode Island
United States Research Site Sandusky Ohio
United States Research Site Santa Ana California
United States Research Site Sayre Pennsylvania
United States Research Site Seattle Washington
United States Research Site Spokane Washington
United States Research Site Tallahassee Florida
United States Research Site Torrance California
United States Research Site Tucker Georgia
United States Research Site Ventura California
Venezuela Research Site Caracas Miranda
Venezuela Research Site Valencia Carabobo

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Countries where clinical trial is conducted

United States,  Venezuela,  Argentina,  Australia,  Belgium,  Brazil,  Canada,  China,  Colombia,  Denmark,  Finland,  France,  Germany,  India,  Italy,  Japan,  Korea, Republic of,  Mexico,  Netherlands,  Norway,  Portugal,  Romania,  Spain,  Turkey,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary MI, unstable angina with urgent revascularization, stroke, and death for any cause Event rates (time to first occurrence of any event from the composite of MI, unstable angina with urgent revascularization, stroke or death for any cause) in a three-year follow-up period. in a 3-year follow-up period
Primary Healthcare resource utilization Healthcare resource utilization associated with the events (MI, unstable angina with urgent revascularization, stroke or death for any cause) in a three-year follow-up period. in a 3-year follow-up period
Secondary Ischemic events (MI, unstable angina with urgent revascularization, ischemic stroke, CV death or death with unknown reason) To describe the rate of ischemic events (time to first occurrence of any event from the composite of MI, unstable angina with urgent revascularization, ischemic stroke, CV death or death with unknown reason) in a three-year follow-up period. in a 3-year follow-up period
Secondary Bleeding events which require medical attention To describe the rate of bleeding events requiring medical attention. in a 3 year follow-up period

External Links